Theravance Biopharma, Inc.TBPHNASDAQ
Loading
Direct costs attributable to producing goods sold
3Y CAGR
-55.7%/yr
vs +206.9%/yr prior
Acceleration
-262.5pp
Decelerating
Percentile
P57
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $5.51M | - |
| 2024 | $0.00 | -100.0% |
| 2023 | $40.62M | -35.9% |
| 2022 | $63.39M | -67.3% |
| 2021 | $193.66M | - |
| 2020 | $0.00 | - |
| 2019 | $0.00 | -100.0% |
| 2018 | $715000.00 | -88.1% |
| 2017 | $6.03M | +108.4% |
| 2016 | $2.89M | - |